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Abstract
Background: Mindfulness based interventions (MBIs) are increasingly used to help patients cope with physical and
mental long-term conditions (LTCs). Epilepsy is associated with a range of mental and physical comorbidities that
have a detrimental effect on quality of life (QOL), but it is not clear whether MBIs can help. We systematically
reviewed the literature to determine the effectiveness of MBIs in people with epilepsy.
Methods: Medline, Cochrane Central Register of Controlled Trials, EMBASE, CINAHL, Allied and Complimentary
Medicine Database, and PsychInfo were searched in March 2016. These databases were searched using a combination
of subject headings where available and keywords in the title and abstracts. We also searched the reference lists of
related reviews. Study quality was assessed using the Cochrane Collaboration risk of bias tool.
Results: Three randomised controlled trials (RCTs) with a total of 231 participants were included. The interventions
were tested in the USA (n = 171) and China (Hong Kong) (n= 60). Significant improvements were reported in depression
symptoms, quality of life, anxiety, and depression knowledge and skills. Two of the included studies were assessed as
being at unclear/high risk of bias - with randomisation and allocation procedures, as well as adverse events and reasons
for drop-outs poorly reported. There was no reporting on intervention costs/benefits or how they affected health service
utilisation.
Conclusion: This systematic review found limited evidence for the effectiveness of MBIs in epilepsy, however preliminary
evidence suggests it may lead to some improvement in anxiety, depression and quality of life. Further trials with larger
sample sizes, active control groups and longer follow-ups are needed before the evidence for MBIs in epilepsy can be
conclusively determined.
Keywords: Mindfulness, Epilepsy, Systematic review, Stress, Anxiety, Depression
Background
The prevalence of stress, anxiety, and depression is
higher among people with epilepsy when compared with
the general population, and suicide rates are similarly
elevated [1–5]. The prevalence of anxiety among people
with epilepsy is estimated to be between 10 and 25% [5],
whilst Fiest et al. [6] reported a 13% lifetime prevalence
of depression.
Stress is widely recognised as a risk factor for develop-
ing both anxiety and depression, and may also be a trig-
ger for seizures in people with epilepsy [7]. For example,
epileptics report stress as one of the main precipitants of
seizures [7, 8], and chronic stress has been linked to a
higher frequency of seizures [9–12]. The unpredictability
of recurrent seizures and a resultant feeling of lack of
control can be stressful, as can concern about potential
for injury during a seizure [7, 13–15]. Moreover, anti-
epileptic medications can have unpleasant side effects
[14, 16, 17], and having a diagnosis of epilepsy can limit
an individual’s employment opportunities and render
them unable to drive [7, 14]. Comorbid anxiety, depres-
sion, and stress negatively influence quality of life (QOL)
in people with epilepsy [3, 4] and are likely to be under-
reported, under-diagnosed, and under-treated [18, 19].
Psychological therapies can form a useful component of
treatment of mental health disorders in epilepsy [20, 21].
For example, a recent systematic review [22] found that
“…psychotherapy can improve depression and anxiety in
patients with epilepsy”. In this context, Tang et al. [21]
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describe the primary aim of psycho-behavioural therapies
in epilepsy to improve the ability of the individual to cope
with their illness, but additionally note they may improve
“seizure control and psychological well-being”. A com-
monly used psychological treatment is Cognitive Behav-
ioural Therapy (CBT). A systematic review of CBT for
people with epilepsy suggested that CBT interventions
which are orientated towards treating depression ra-
ther than seizure control are “likely efficacious” and
supported the use of CBT in some “clinical practice
recommendations” [23].
Mindfulness-based interventions (MBIs) are increas-
ingly used to treat stress and mental health comorbidi-
ties in people with long-term conditions (LTCs),
including other neurological conditions such as multiple
sclerosis [24] and stroke [25]. Mindfulness interventions
are typically based on Mindfulness Based Stress Reduc-
tion (MBSR) which has three core meditation practices
(the ‘body scan’, ‘following the breath’ and ‘mindful
movement’) [26, 27]. The highest quality evidence for
MBIs is for recurrent depression [28–30]. MBIs could
potentially offer a further treatment option for people
with epilepsy; however the effectiveness of MBIs for this
group has not previously been reviewed. An important
safety consideration is that case reports exist suggesting
that meditation training might be associated with an in-
creased risk of seizures in known epileptics. This is
thought due to neuronal hypersynchrony arising from
meditation practise, however, currently this phenomenon
remains poorly characterised and remains theoretical
[31]. This paper aimed to evaluate the effectiveness of
MBIs in people with epilepsy by means of a systematic
review of the evidence.
Methods
Protocol
A protocol for this review is available [32].
Selection criteria
To enable the identification and selection of the best
available evidence regarding the therapeutic benefits of
MBIs for people with epilepsy we determined inclusion
criteria relating to Population, Interventions, Compara-
tor and Outcomes (PICO) (Table 1).
Search strategy
In March 2016 a systematic search for published and
unpublished studies was conducted in six major
electronic bibliographic databases: Cochrane Central
Register of Controlled Trials, MEDLINE, EMBASE,
CINAHL, Allied and Complementary Medicine Data-
base, and PsycInfo. Selected medical subject headings
were combined with key words relating to epilepsy
and mindfulness to create a search strategy, which
Fig. 1 Flow Diagram
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was finalised for use in MEDLINE (Additional file 1)
and amended for use in the other databases, using
appropriate controlled vocabulary, Boolean operators,
and search symbols. The databases searched retrieve
conference abstracts, theses and dissertations; in
addition key words were used to conduct a basic
search of Google. Delimiters were: dates searched
(1980–2016); research subjects (human); and language
(English). RefWorks was used to store and manage
the results of the database searches.
Selection of papers for inclusion
The bibliographic records identified by the searches were
screened for relevance using broad inclusion criteria, i.e.,
‘epilepsy’ and ‘mindfulness’. All relevant papers were then
screened, using the PICO inclusion criteria (Table 1), to
select eligible papers. All selected papers were subject to
methodological appraisal. Methodological quality was
assessed using the Cochrane Risk of Bias tool [33]. Quality
was assessed as being of low/unclear/high risk of bias
against seven criteria: random sequence generation (selec-
tion bias), allocation concealment (selection bias), blinding
of assessors (performance bias), blinding of outcome as-
sessment (detection bias), incomplete outcome data (attri-
tion bias), selective reporting (reporting bias), and ‘other’.
Due to the paucity of available evidence, no papers were
excluded on the grounds of quality. However, methodo-
logical issues are discussed below and reported in the evi-
dence table.
Data extraction
Data, including details of study design and methods, in-
terventions (delivery and content), populations, and pri-
mary and secondary outcomes, were extracted from
papers using a data extraction tool developed by the au-
thors. All screening and assessment processes for each
paper were conducted by two reviewers who worked inde-
pendently and then met to discuss and agree the outcomes;
any disagreements were resolved consensually (Fig. 1).
Data synthesis
Due to the heterogonous nature of the papers included
in the review, meta-analyses were not possible; therefore,
the review findings are presented in narrative form.
Results
The three studies included in the review were based in
the USA - involving 53 participants [34] and 118 partici-
pants [35] - and also in China (Hong Kong) involving 60
participants [36]. Most participants were female and
mean age varied from 34.77 years (intervention group
[36]) to 41.2 years (all participants [35]). The majority of
participants were White/Caucasian in the two studies
which reported ethnicity [34, 35] (Table 2). All partici-
pants had been diagnosed with epilepsy; those in the
Tang et al. [36] study were required to have a diagnosis
of epilepsy resistant to antiepileptic drug treatment, and
the study outlined participants’ type of epilepsy, mean
duration of diagnosis, age at diagnosis, number and type
of epileptic medications, seizure frequency, last seizure
and co-morbidities. However, information pertaining to
participants’ epilepsy was poorly reported in Thompson
et al. [34] and not at all by Thompson et al. [35].
Participant baseline characteristics were reported sep-
arately for intervention and control groups in Thompson
et al. [34] and Tang et al. [36] but for participants as a
whole in Thompson et al. [35] (and not in table format),
with the authors stating that the intervention and treat-
ment as usual (TAU) group differed on only one baseline
characteristic (number of days in last 30 of activity limi-
tation due to poor physical health, t = 1.96, df = 116, p =
0.05) which was controlled for in subsequent analyses.
In addition, in Thompson et al. [35] the difference in
PHQ-9 scores between intervention and TAU at baseline
“approached significance (t = 1.88, df = 116, p = 0.062),
with the mean for depressive symptoms in the inter-
vention group (6.9), greater than that in the TAU
group (5.5).”
Participants were recruited from a hospital-based
epilepsy clinic [34], multiple clinical populations
which the participating university sites had access to
[35] and from a hospital’s neurology clinics [36]. In-
clusion criteria were clearly presented by all studies.
However, exclusion criteria were less well described
Table 1 PICO criteria
Population Adult patients (aged 18 years or older)
with a clinical diagnosis of epilepsy will
be included.
Interventions Trials which solely focus on, or incorporate
a Mindfulness intervention where the
mindfulness data can be extracted, will be
selected. As with many other mind-body
interventions, Mindfulness as a therapeutic
intervention is inherently varied and
heterogeneous. Thus different forms,
duration and frequency of Mindfulness
interventions will be included [45].
Comparator Usual care or any active comparator
Outcome measures Confidence
Well-being
Anxiety depression
Social participation
Perceived self-health
Quality of Life
Physiological outcomes e.g., blood
pressure
Seizure frequency; seizure duration
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by Thompson et al. [35]. Each of the studies incorpo-
rated quantitative measures only.
Design/aims of the studies
The three included studies were RCTs; both Thompson
et al. [34] and Thompson et al. [35] employed a stratified
randomised crossover design. The study by Thompson
et al. [34] was a pilot, exploring the acceptability and
efficacy of a Mindfulness-Based Cognitive Therapy
(MBCT) based intervention (Project UPLIFT) in redu-
cing depression, increasing knowledge, skills and self-
efficacy and improving QOL among people with epilepsy
and depression. Thompson et al. [35] aimed to evaluate
the efficacy of the same intervention (Project UPLIFT
with language modified for prevention) in reducing de-
pressive symptoms and preventing major depressive dis-
order episodes (MDD) for people with epilepsy, and
expanding its use to other geographical sites. Both
Thompson et al. [34] and Thompson et al. [35] com-
pared TAU with the delivery of the mindfulness course
by either telephone or internet. The Tang et al. [36]
assessor-blinded RCT aimed to investigate the effects of
mindfulness-based therapy (MT) and social support (SS)
for people with drug-resistant epilepsy, primarily the
effect on QOL. The study involved MT plus SS as the
“active treatment condition” and “social support alone
(SS) as an attention placebo control”.
Mindfulness interventions
In the Thompson et al. [34] study the researchers “cre-
ated eight cognitive therapy and mindfulness sessions”,
targeted at people with epilepsy. The same intervention
was utilised by Thompson et al. [35], with language
modified to reflect preventing depressive symptoms in
epilepsy. The interventions consisted of eight weekly ses-
sions, lasting one hour [34, 35]. The MT in Tang et al.
[36] involved four bi-weekly sessions lasting two and a
half hours and was based on a protocol developed with
reference to Kabat-Zinn [37], Hofmann et al. [38], Dahl
et al. [39] and Kabat-Zinn [40]. None of the studies in-
corporated a day retreat which is a standard component
in the most commonly used and researched MBI,
Mindfulness-Based Stress Reduction (MBSR) (Table 3).
Delivery
All three interventions were group-based, with group
size ranging from six to eight. However, the MBCT in-
terventions in Thompson et al. [35] and Thompson et
al. [34] were delivered to participants in their own
homes via telephone or the internet and were co-
facilitated by a layperson with epilepsy and a Public
Health Masters student research assistant or graduate
student with a ‘Mental Health concentration in Public
Health’, who were supervised by a licensed clinical
psychologist. The Thompson et al. [35] intervention was
manualised, and a script used to deliver the course on-
line and by telephone – participants could interact in
the telephone conferences or on the internet forum. In
contrast, the MT in Tang et al. [36] was delivered face-
to-face by a clinical psychologist.
Four hours of training was provided for facilitators in
Thompson et al. [35] along with a practice session deliv-
ered by the Principal Investigator (a licensed clinical
psychologist and Associate Professor of Behavioural
Sciences, Psychiatry and Epidemiology). Training, quali-
fications and/or clinical experience of facilitators in de-
livering mindfulness therapy was not specified in
Thompson et al. [34] and Tang et al. [36].
Participants in Thompson et al. [34] and Thompson et
al. [35] were paid for their participation in the mindful-
ness course sessions ($15 per session) and the comple-
tion of study assessments ($25 per assessment).
Participants in Tang et al. [36] did not receive any remu-
neration for taking part in the study.
Content
The mindfulness course piloted in Thompson et al. [34]
provided information to increase knowledge about de-
pression and epilepsy, incorporating both CBT and
mindfulness techniques (Table 3). Mindfulness exercises
included attention to breath, sights and sounds and
other meditations; the intervention also utilised the body
scan and progressive muscular relaxation (PMR). The
same course was used as the basis of the intervention in
Thompson et al. [35] “with language modified for use in
prevention” of depressive episodes and reducing depres-
sive symptoms. The study by Tang et al. [36] aimed to
improve participants’ knowledge and management of
epilepsy, with the course also providing training on
mindfulness techniques - mindful breathing, −eating,
−observing and the body scan. Mindfulness concepts
such as the mind-body connection, awareness of
thoughts, and a non-judgemental attitude, among others
were also incorporated into the intervention.
Intervention materials
Intervention materials provided to participants were not
clearly described across the studies. In Thompson et al.
[34], participants receiving the intervention via the inter-
net were provided with a manual on how to use the
website. All participants were given access to session
materials (although it is unclear what these constituted)
and a CD containing relaxation and meditation exer-
cises. Less information was provided in Thompson et al.
[35], however session content was made available on an
accessible archive for internet participants, who could
also use an online discussion board. In Tang et al. [36],
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all participants were provided with an ‘educational pack-
age’ on epilepsy and its management.
Control group treatment
Participants in the attention placebo control group in
Tang et al. [36] participated in a social support group
with the same hours and group format as the mindful-
ness intervention. The first session of the group focused
on psycho-education concerning epilepsy, and the
remaining three sessions provided a supportive environ-
ment for sharing and reinforcing epilepsy management.
Control participants in Thompson et al. [34] and
Thompson et al. [35] received TAU and continued with
their usual medication and/or therapy, but this was not
clearly described. Due to the crossover design of these
studies, control participants also received the mindful-
ness intervention.
Outcomes
Data collection
Data were collected at three time points in Thompson et
al. [34] and Thompson et al. [35] – pre-test, interim
Table 3 Study description
Study Country Follow-up Period Intervention
Thompson et al. (2010) [34] USA 8 weeks • Based on Mindfulness-Based Cognitive Therapy
• Hour long sessions for eight weeks
• Delivered via telephone or internet
• Groups of six to eight participants
• Facilitated by layperson with epilepsy and Master of Public Health
Student Research Assistant – supervised by a licensed clinical psychologist.
Mindfulness teaching certification/experience level not clear.
• Sessions consisted of: check-in, instruction (video instruction – internet)
skill building, discussion, homework assignment
• Course content: attention to breath, sights and sounds; other meditations;
body scan; progressive muscular relaxation; thought monitoring, identifying
cognitive distortions, self-esteem, problem identification, goal-setting,
identifying supports.
• All participants had access to session materials and CD of relaxation and
meditation exercises. Internet participants had access to online discussion
forums.
• Homework assignments given including monitoring thoughts, changing
thoughts, practicing relaxation exercises, meditation exercises and
mindfulness. Duration not specified.
Thompson et al. (2015) [35] USA 10 weeks • Based on Mindfulness-Based Cognitive Therapy, was script-based
• Hour long sessions for eight weeks
• Delivered via telephone or internet
• 22 groups of up to seven participants
• Facilitated by an adult with epilepsy and a graduate student with Mental
Health Concentration in Public Health. Supervised by a licensed clinical
psychologist and Associate Professor of Behavioural Sciences. Mindfulness
teaching certification/experience level not clear, however four hours of
training provided
• Sessions consisted of: check-in period, teaching on topic of that week’s
session, group discussion, skill-building exercise, homework assignment
• Course content: knowledge about depression; monitoring and challenging,
and changing thoughts; coping and relaxing; attention and mindfulness;
focusing on pleasure; importance of reinforcement; preventing relapse.
• Internet participants had access to archive of sessions and a discussion
board.
• Homework assignments given, duration not specified
Tang et al. (2015) [36] China (Hong Kong) 6 weeks • Mindfulness Therapy (experiential, progressive training on mindfulness
techniques) plus social support
• Four 2.5 hour bi-weekly sessions
• Delivered in person
• Groups of seven to eight participants
• Facilitated by clinical psychologist. Mindfulness teaching certification/
experience level not clear.
• Course content: Knowledge and management of epilepsy; mind-body
connection; Mindful breathing, eating, listening, observing; body scan;
non-judgemental attitude, variation of thoughts, thought labelling.
• All participants received an educational package on basic knowledge and
management of epilepsy
• 45 minutes of daily mindfulness practice encouraged. Homework assignments
included recording thoughts and bodily sensation associated with recurrent
seizure attack
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(after the end of the MBCT eight week intervention)
and post-assessment (after the end of the TAU interven-
tion). Two data collection points were utilised in Tang et
al. [36], baseline (including six-week prospective baseline
period) and post-intervention – (six weeks following the
last intervention session). Only Tang et al. [36] described
performing a sample size calculation (60 participants),
statistical power (0.8) and effect size (0.74) to detect
change in QOL scores (QOLIE-31-P). Thompson et al.
[35] noted an effect size (r = 0.20) to detect change in
depression symptoms, while Thompson et al. [34] stated
that they “designed and powered this study to detect
change in depressive symptoms over 8 weeks using the
BDI” (Beck Depression Inventory) without further detail
(Table 4).
Epilepsy measures
In Tang et al. [36] participants were required to keep a
seizure diary during the span of the study and to
complete a Seizure Severity Questionnaire. Significant
reductions were found in frequency of seizures (F =
25.51, p < 0.001 hp2 = 0.306, 95% CI −3.96, −1.64) with
the group-by-time interaction being statistically significant
(F = 5.90, p = 0.018, hp2 = 0.092). In addition, there was a
statistically significant reduction in severity of seizures
(F = 15.28, p < 0.001, hp2 = 0.209, 95% CI −0.91,
−0.29), although there was no significant difference
between the two groups. Studies Thompson et al. [34]
and Thompson et al. [35] did not measure epilepsy-
related outcomes such as seizure frequency.
Depression
All of the studies utilised variations of the Beck Depres-
sion Inventory (BDI): Beck Depression Inventory-II
(BDI-II) [36]; BDI and modified BDI (mBDI) [34, 35]. In
addition to these measures, Thompson et al. [34]
included the Depression Coping Self-Efficacy Scale
(DCSES), whilst Thompson et al. [35] incorporated the
DCSES, the Neurological Disorders Depression Inven-
tory for Epilepsy (NDDI-E) and PHQ-9 (which was ini-
tially used to exclude participants with baseline scores
indicative of MDD).
Both Thompson et al. [34] and Thompson et al.
[35] reported significant reductions in depressive
symptoms among intervention participants. Thomp-
son et al. [34] found statistically significant reductions
Table 4 Study outcomes and main findings
Author (Year) Main outcomes Main findings
Thompson et al.
(2010) [34]
Depressive Symptoms (Beck Depression Inventory
and Modified form)
Self-Efficacy (Depression Self-Efficacy Scale DCSES)
Satisfaction with life (Satisfaction With Life Scale SWLS)
Quality of Life (Behavioural Risk Factor Surveillance
System BRFSS)
Self-Compassion (Self-Compassion Scale SCS)
Knowledge and Skills assessment
Decrease in depressive symptoms among intervention group
significantly better than control, and greater for those attending
more sessions.
No statistical difference in efficacy in relation to presence of MDD.
Telephone group results slightly better than internet group but
not significant.
Intervention group increased knowledge and skills more than control
group; and increases were greater among those who attended more
sessions. Change in knowledge and skills were negatively correlated
with change in BDI score.
Change in Satisfaction with Life approached significance. No significant
improvement in physical and mental health QOL measures, but
improvement greater in intervention group.
Thompson et al.
(2015) [35]
Depressive Symptoms (Beck Depression Inventory and
Modified form; Neurological Disorders Depression
Inventory for Epilepsy NDDI-E; PHQ-9)
Depression Coping Self-Efficacy (Depression Coping
Self-Efficacy Scale DCSES)
Self-Compassion (Self-Compassion Scale SCS)
Satisfaction with Life (Satisfaction With Life Scale SWLS)
Quality of Life (Behavioural Risk Factor Surveillance System)
Knowledge and Skills assessment
Depressive symptoms – no difference between telephone and
internet groups. Significant improvement in intervention group
and had less depressive episodes. Association between scores
and number of sessions attended.
Knowledge and skills improvements greater in intervention
group, and associated with number of sessions attended.
Changes significantly associated with change in mBDI scores.
Knowledge and skills mediated change in mBDI scores between
intervention and controls.
Satisfaction with life increased in intervention group, and associated
with number of sessions attended.
Changes in Depression Coping Self Efficacy and Physical and
Mental Health Quality of Life and Self-Compassion not significant.
Tang et al.
(2015) [36]
Quality of Life (Patient-Weighted Quality of Life in
Epilepsy Inventory QOLIE-31-P)
Depressive Symptoms (Beck Depression Inventory-II,
BDI-II)
Anxiety Symptoms (Beck Anxiety Inventory, BAI)
Control and intervention group statistically significant improvement
in quality of life and anxiety scores. Improvements statistically
significantly better in intervention group.
Statistically significant reduction in BDI-II scores in both groups,
not clinically significant.
Significant reduction in seizure frequency and severity in both groups.
Significant improvement in verbal and non-verbal memory. No other
differences in Cognitive Functioning.
BDI Beck Depression Inventory, MDD Major Depressive Disorder, mBDI modified Beck Depression Inventory, QOL Quality of Life
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in BDI (F1,37 = 11.99, p = 0.001) and mBDI (F1,37 =
10.08, p = 0.003) scores. Similarly Thompson et al.
[35] found statistically significant reductions in BDI
(F1,106 = 4.50, p = 0.036) and mBDI (F1,106 = 4.67, p =
0.033); the study also found that intervention partici-
pants experienced fewer depressive episodes than
TAU participants (p = 0.028). Both studies reported a
dose-response relationship, with participants who
attended more sessions, experiencing the largest re-
ductions (F2,35 = 1.53, p = 0.23 [not statistically signifi-
cant] [34]). In terms of the outcomes for participants
in either the telephone or internet groups, Thompson
et al. [35] found no difference based on allocation
(mBDI: F1,50 = 0.02, p = 0.88), whilst Thompson et al.
[34] found that depressive symptoms decreased more
among the telephone group, however this difference
was not significant.
The intervention group in Thompson et al. [35]
were also found to have a greater decrease in NDDI-
E scores, but this was not significant (F1,106 = 0.35, p =
0.555). No significant difference was found between
groups on the DCSES in Thompson et al. [34] (F1,37 =
2.14, p = 0.152) and Thompson et al. [35]. In addition,
Thompson et al. [34] suggested that the intervention was
“equally effective regardless of anti-depressant medication
or psychotherapy” (however study was not powered to
detect this).
Thompson et al. [35] reported that participants in the
intervention group were less likely to experience an inci-
dence of MDD than those in the TAU group (p = 0.028).
In addition, a greater decrease in depressive symptoms
was found among the intervention group than the TAU
group which approached significance for the PHQ-9
(F1,106 = 2.75, p = 0.100), and when the analysis was limited
to those who provided both baseline and interim data the
results were significant (F1,104 = 3.895, p = 0.050).
In Tang et al. [36] there was a statistically significant
reduction in depressive symptoms measured by BDI-II
scores in both groups after treatment. However, there
was no statistically significant difference on severity cat-
egory pre- and post-intervention (p = 0.125 both groups).
This implies that the improvement in BDI-II scores was
of no clinical significance.
Anxiety
Only Tang et al. [36] measured anxiety, using the Beck
Anxiety Inventory (BAI). Both the MT and SS groups
showed a statistically significant reduction in anxiety
scores post-intervention (F = 23.44, p < 0.001, hp2 =
0.288, 95% CI −6.44, −1.76). Using McNemar tests, it
was shown that there was a clinically significant reduc-
tion in the MT group (p = 0.012) but not the SS group
(p = 0.065) between pre-and post-intervention.
Quality of Life measures
An epilepsy specific QOL measure was used in Tang et
al. [36] - Quality of Life in Epilepsy Inventory (QOLIE-
31-P). The Satisfaction with Life Scale (SLS) and Behav-
ioural Risk Factor Surveillance System (BRFSS) were
used in Thompson et al. [34] and Thompson et al. [35].
Satisfaction with life improved significantly in the inter-
vention group compared with the control group in
Thompson et al. [35] (F1,106 = 8.02, p = 0.006), associated
with number of sessions attended, while the improve-
ment in Thompson et al. [34] approached significance
(F1,37 = 3.029, p = 0.090). In both studies physical and
mental health QOL measures improved (most for the
intervention group in Thompson et al. [34]), but were
not statistically significant. In contrast, Tang et al. [36]
found statistically significant improvement in QOL in
both the intervention and SS control group (F1,58 =
30.35, p < 0.001, hp2 = 0.334, 95% CI +3.38, +7.24), with
the improvement in the intervention group being clinic-
ally important in more participants and statistically sig-
nificantly better (χ2 (1) = 4.356, p = 0.037, φ = 0.269).
Other aspects of QOL were also found to have improved
including energy, mood, medication effect and seizure
worry.
Thompson et al. [35] also measured self-compassion
using the Self-Compassion Scale (SCS) but found no sig-
nificant change.
Knowledge and Skills
Change in knowledge and skills relating to depression
were assessed in Thompson et al. [35] and Thompson et
al. [34] using the same measure, originally developed for
use in the earlier study. Both reported a statistically sig-
nificant improvement in scores (F1,37 = 4.75, p = 0.036
[34]; F1,106 = 6.01, p = 0.016 [35]) with improvements
greater for those attending more sessions, however
Thompson et al. [34] noted that this was not statistically
significant (F2,35 = 0.47, p = 0.63).
According to Thompson et al. [34], a change in know-
ledge and skills score was “significantly negatively corre-
lated with change in BDI score (r = −0.389, p = 0.013)”.
In addition, mBDI scores were found to be significantly
associated with changes in knowledge and skills scores
(r = −0.30, p = 0.002) in Thompson et al. [35]. This study
also found that change in knowledge and skills mediated
the relationship between change in mBDI scores in the
control and intervention groups, which was evaluated
using structural equation modelling.
Cognitive functioning
Cognitive functioning was assessed using a number of
measures in Tang et al. [36]. These included: Chinese
Auditory Verbal Learning Test; Rey Complex Figure
Test and Recognition Trial; Category Fluency Test; Digit
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Span Test; Stroop Colour and Word Test – Victoria ver-
sion. Improvements were found in verbal and non-
verbal memory; no differences were reported for fluency,
Digit Span Test and Stroop Colour and Word Test.
However, the authors noted that practice effects could
have affected these findings and so should be treated
with caution. Cognitive functioning was not assessed by
Thompson et al. [34] and Thompson et al. [35].
Quality appraisal
Using the Cochrane Collaboration ‘Risk of Bias’ tool
(Table 5), studies by Thompson et al. [34] and Thomp-
son et al. [35] were assessed as being at unclear/high risk
of bias; the study by Tang et al. [36] was assessed as be-
ing at low risk. Thompson et al. [34] was considered to
be at high risk of performance and detection bias –
“neither the participants nor the project staff were
blinded to the group assignment”. The study was also
judged as being at high risk of attrition bias because of
missing data not being described and further due to the
study’s repeated measures design, only participants who
completed interim assessments were included in ana-
lyses. The Thompson et al. [35] study was at high risk of
selection bias as the randomisation and allocation proce-
dures were not described and some participants rando-
mised to the intervention group were able to choose
whether to receive the intervention by phone or
internet.
Discussion
This review identified three studies which reported the
findings of RCTs utilising MBIs in the treatment of
people with epilepsy. The primary outcomes assessed in
the three included papers were depression [34, 35] and
QOL [36] and each reported that there may be some
benefit associated with the use of MBIs for people with
epilepsy. Thompson et al. [34] and Thompson et al. [35]
found significant reductions in depressive symptoms. In
relation to QOL, Tang et al. [36] reported a statistically
significant improvement; Thompson et al. [35] also re-
ported an improvement in QOL. Other outcomes also
found to have improved following an MBI included anx-
iety [36] and depression knowledge and skills [34, 35].
This review included only three articles for final data
extraction which limits the applicability of the findings.
Despite positive findings, their generalisability and reli-
ability are limited by several factors. As previously noted
two of the studies were at unclear/high risk of bias -
randomisation and allocation procedures, adverse events
and reasons for drop-outs were poorly reported. Fur-
thermore, two of the papers were described as being
underpowered - Thompson et al. [34] highlighted that
their study was not sufficiently powered to find statisti-
cally significant differences in satisfaction with life
scores. Moreover, Thompson et al. [35] noted that, as
the study was powered to identify any differences in
depressive symptoms, it was limited in power to detect
“smaller differences seen in self-efficacy and self-
compassion, or changes seen at follow-up”. In addition,
all studies noted their results and generalisability were
limited by taking place in just one site [34, 36], or over a
small number of sites [35]. All studies also highlighted
their short follow-up periods and lack of measurement
of longer-term effects. Tang et al. [36] also noted pos-
sible limited accounting for confounding factors such as
anti-epileptic medications and other uncontrolled vari-
ables. In addition participants’ home practice was not
measured across the studies.
Demographic and epilepsy characteristics of partici-
pants were poorly reported in Thompson et al. [34] and
Thompson et al. [35] limiting the extent to which the
role of these factors could be examined. Furthermore, all
participants in Tang et al. [36] had drug-resistant epi-
lepsy; it is therefore unclear whether the same outcomes
could be expected among those whose epilepsy is not
drug-resistant. In addition, as the included studies uti-
lised different variations of MBIs, caution should be used
in comparing results across studies.
To our knowledge no other systematic reviews have
focused on the use of MBIs alone for people with epi-
lepsy. However other systematic reviews have included a
wider range of psychological treatments, some involving
aspects of mindfulness. A review of psychological treat-
ments for epilepsy (including relaxation therapies, CBT
and educational interventions) suggested there may be
“a possible beneficial effect on seizure frequency” while
“no reliable conclusions” could be reached on the effects
of psychological treatments on psychological outcomes
and QOL [41] (has been recalled to be superseded). A
further review [22] examined treatments (antidepressant
medications, antiepileptic medications and CBT - in-
cluding Thompson et al. [34]) for people with comorbid
epilepsy and depression, and suggested CBT could im-
prove health outcomes although a number of methodo-
logical limitations were identified and questions raised
about implementation.
As the scope of this review was restricted to MBIs, in-
terventions that included only some aspects of mindful-
ness were excluded. For example, Acceptance and
Commitment Therapy (ACT) and Yoga for patients with
drug-refractory epilepsy have been found to improve
seizure frequency and QOL in RCTs [42, 43]. Yoga inter-
ventions were also excluded from the review; however
a study by Panjwani et al. [44] suggested that Sahaja
Yoga practice reduced stress levels among participants
with epilepsy.
The findings of this review were limited due to the
small number and poor quality of studies included.
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It was not possible to conduct a meta-analysis and
results were therefore presented in a narrative for-
mat. In addition, we were unable to locate the full
paper for one study at the full paper screening stage
– the paper was therefore excluded. Furthermore,
for pragmatic reasons our search strategy did not in-
clude an extensive grey literature search. However
we did conduct a basic (as opposed to advanced)
search of Google and searched electronic databases
that index grey literature items. A strength is that as
previously noted, we are not aware of another review
focusing on the use of MBIs for people with epilepsy
and it has therefore been valuable in determining
the extent of existing research in this area.
Conclusions
Further research is required before conclusions can be
reached on the effectiveness of mindfulness as a thera-
peutic intervention for people with epilepsy. In order to
establish longer-term outcomes of participation in MBIs,
larger RCTs with longer follow-up periods and active
control groups are required along with more detailed in-
formation relating to participants’ epilepsy.
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